Please login to the form below
cancer
This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca buys FDA priority review voucher from Sobi
However the company suffered a setback yesterday when it announced another failure of Imfinzi in combination with tremelimumab in first-line non-small cell lung cancer.
Latest news
-
BeiGene gets speedy US review for lymphoma drug zanubrutinib
inhibitor for ovarian cancer.
-
AZ’s Imfinzi combo bombs again in non-small cell lung cancer
further undermining hopes of a challenge to Merck &Co’s Keytruda in first-line non-small cell lung cancer (NSCLC). ... from this trial to gain further insights to improve immuno-oncology approaches for patients with metastatic non-small cell lung cancer
-
Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
Prior to joining Lilly in 2017, Garraway was director of the Joint Centre for Cancer Precision Medicine, an organisation that brings together the expertise of Harvard teaching hospitals. ... The company has just picked up a new approval for targeted
-
BMS buoyed by FDA approval of Celgene’s myelofibrosis drug
The merger is intended to counteract a slowdown in its cancer business and create a combined company with an enhanced pipeline and improved sales growth. ... Fedratinib was one of the late-stage development programmes highlighted by BMS when the merger
-
Sanofi patent case win holds off generic rivals for key cancer drug
Lourie’s conclusion boosts Sanofi’s hopes of eking more money out of Jevtana, which came to market in 2010 as a treatment for prostate cancer patients. ... The performance made Jevtana Sanofi’s top selling cancer drug, accounting for almost 30% of
More from news
Approximately 633 fully matching, plus 2,861 partially matching documents found.
Latest Intelligence
-
AI is transforming pharma R&D – now it can transform pharma marketing
In May 2019, Google reported that its AI could detect early signs of lung cancer in CT scans, in some cases identifying cancers missed by trained oncologists. ... A successful colonoscopy may prevent a cancer being missed, so Ava might help save lives!
-
The evolution of real-world studies
Pfizer and the FDA shed light on the evolution of RWE in April when breast cancer drug Ibrance secured approval in a new indication on the strength of data from electronic ... The RWE-focused strategy enabled Pfizer to work round the rarity of male
-
The Cystic Fibrosis Buyers’ Club
This includes overriding pharma patents – something the group is advocating in relation to three drugs – Vertex’s cystic fibrosis treatment Orkambi, Pfizer’s breast cancer treatment Ibrance and Roche’s breast ... cancer drug Perjeta.
-
Building Europe’s next breakthrough biotechs
life sciences campus in central Cambridge where AstraZeneca, Cancer Research UK and other leading research organisations are based.
-
Biotech profile: Tom Evans, CEO, Vaccitech.
You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine for prostate cancer in phase 1. ... How big a role do you think therapeutic vaccines will play in future cancer treatment?
More from intelligence
Approximately 8 fully matching, plus 275 partially matching documents found.
Latest appointments
-
Lucid Group announces new hires at its creative and digital agency Bluedog
Finally, Victoria William joins Bluedog as a senior account executive. William has two years’ experience working at an independent creative healthcare agency, and also has a MSc in cancer cell biology.
-
F-star hires ex-BMS immuno-oncology leader
pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never ... He is an active member of the American Society of Clinical
-
New hires at Ferring, Flexion and Immunocore
It’s the first major appointment for Ferring in 2019, and the company says Opdyke will lead the potential commercial launch of its investigational gene therapy for bladder cancer patients in ... He said: “At the heart of cancer immunity is a T cell
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
He started his career with Eurand in Italy, and since 2011 he has worked for Helsinn Healthcare, a cancer care company.
More from appointments
Approximately 5 fully matching, plus 203 partially matching documents found.
Latest from PMHub
-
Empowered patients: shaking the foundations of healthcare
Those practicing in a community care setting often lack knowledge of precise treatments, as shown in our interview with breast cancer survivor Laura Holmes-Haddad (on p.10). ... As a result, the ‘zip code lottery’ and patients’ financial
-
Mednet Group’s growth spurt
in cancer biology and she has experience working as a research technician in the field of malignant haematology. .
-
Qualitative segmentation validation study with backroom brainstorm exercises
Our client had an oncology product in development for the treatment of prostate cancer.
-
Bluedog is bursting with new creative and digital talent
Finally, Victoria William joins Bluedog as a senior account executive. Victoria has an MSc in cancer cell biology and two years’ experience working at an independent creative healthcare agency.
-
Precision paediatrics: Treating patients with CAR-T
The therapy works by modifying T-cells to weaponise them against cancer cells. ... SA: CAR-T cell therapy is an innovative immunotherapy that modifies the body’s own immune T-cells to start attacking cancer cells.
More from PMHub
Approximately 38 fully matching, plus 178 partially matching documents found.
Featured jobs
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- Novo Nordisk shareholder revolt reaches Europe
- AstraZeneca buys FDA priority review voucher from Sobi
- Behaviour change – is there something missing?
- BeiGene gets speedy US review for lymphoma drug zanubrutinib
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
- Pfizer goes big on gene therapy with $500m facility spend
- Empowered patients: shaking the foundations of healthcare
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
